Mar 31, 2026, 01:00 by User Not Found

Clinical Research News | A simple blood test built on a handful of small RNA molecules could reshape how researchers study aging and predict survival. Led by Virginia Byers Kraus, M.D. Ph.D., professor in the departments of medicine, pathology, and orthopedic surgery at Duke University School of Medicine, a team of researchers identified piwi-interacting RNAs (piRNAs) as powerful and potentially causal predictors of mortality in older adults.

Mar 27, 2026, 08:22 by

Lonza has announced the launch of its Media Development Lab at its Singapore site.

Mar 26, 2026, 01:00 by User Not Found

Clinical Research News | Researchers from the Foundation for the National Institutes of Health, Washington University in St. Louis, the University of California San Francisco, the University of Wisconsin-Madison, and other collaborators found that a plasma biomarker—the ratio of phosphorylated to non-phosphorylated plasma tau at position 217, written %p-tau217—can be used to construct a “clock model” that can predict when Alzheimer’s disease symptoms appear.

Mar 25, 2026, 08:20 by

Mar 25, 2026, 08:20 by

Innovation allows for real-time data and operational insights to advance immunology breakthroughs

Mar 25, 2026, 08:20 by

Biopharma PEG highlights high-purity multi-arm PEG reagents designed to support PEGylation research and therapeutic conjugation development

Mar 25, 2026, 08:20 by

Mar 25, 2026, 01:01 by User Not Found

Clinical Research News | Science Corporation’s PRIMA trial results are featured in The New England Journal of Medicine and on the cover of Time; Cognito Therapeutics continues to clinically develop their Spectris platform; and more.

Mar 24, 2026, 08:21 by

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases

Mar 24, 2026, 01:00 by User Not Found

Clinical Research News | Verily Life Sciences and Samsung Electronics America enter a collaboration; Research Solutions launches Scite MCP; Johnson & Johnson receives approval from FDA for TECVAYLI and DARZALEX FASPRO; and more.

Mar 23, 2026, 08:15 by

Bioprocessing leader to drive continued commercial development and international expansion

Mar 20, 2026, 08:05 by

Epigenica AB today announced a distribution agreement with PrimeTech Co., Ltd., bringing Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market.

Mar 20, 2026, 08:05 by

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

Mar 20, 2026, 01:00 by User Not Found

Clinical Research News | In clinical trials, every second counts, both for patient outcomes and sponsor ROI. As data volumes grow and oversight expectations tighten under frameworks like ICH E6(R3), teams are being asked to do more, faster and with greater precision. It is no surprise then that agentic AI, which promises to deliver efficiencies far beyond previous models, is the current hot topic across the industry.

Mar 19, 2026, 07:46 by

The team at ClearNote Health strengthened its leadership team with four key additions.

Mar 17, 2026, 08:25 by

This partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research.

Mar 17, 2026, 01:50 by User Not Found

Clinical Research News | Hypertension, also known as high blood pressure, has long been thought of as primarily a disorder of the heart, kidneys, or blood vessels. A growing body of evidence suggests that, in a substantial proportion of patients, the condition originates in the brain.

Mar 13, 2026, 01:00 by User Not Found

Clinical Research News | Clinical Operations is entering a phase where the hype around artificial intelligence (AI) and digital transformation is giving way to something more meaningful. For the last decade, much of the industry’s effort has focused on layering new technologies onto existing processes. By 2030, that approach will no longer be enough.

Mar 12, 2026, 08:32 by

• Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May • Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery

Mar 12, 2026, 08:32 by

LabConnect has officially opened a new central laboratory facility in Wuxi, China, developed in collaboration with Teddy Laboratory (Frontage Laboratories). The site integrates into LabConnect’s global infrastructure to provide unified data, custom kit building, and biorepository services for multi-regional clinical trials. This expansion brings the company to eight global locations, supporting both multinational firms entering China and Asia-Pacific organizations expanding their research internationally.